|
[1]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
|
|
[2]LIAO XH,CAO X,LIU J,et al.Prevalence and features of fatty liver detected by physical examination in Guangzhou[J].World J Gastroenterol,2013,19(32):5334-5339.
|
|
[3]MARCHESINI G,BUGIANESI E,FORLANI G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome[J].Hepatology,2003,37(4):917-923.
|
|
[4]DU H,CHEN SL,WANG Y,et al.The epidemiology of hyperuricemia and gout in a community population of huangpu district in shanghai[J].Chin J Rheumatol,1998(2):16-19.(in Chinese)杜蕙,陈顺乐,王元,等.上海市黄浦区社区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志,1998(2):16-19.
|
|
[5]SHAO JH,MO BQ,YU RB,et al.Epidemiological study on hyperuricemia and gout in community of Nanjing[J].Chin J Dis Control Prev,2003,7(4):305-308.(in Chinese)邵继红,莫宝庆,喻荣彬,等.南京市社区人群高尿酸血症与痛风的流行病学调查[J].疾病控制杂志,2003,7(4):305-308.
|
|
[6]GU P.The incidence of hyperuricemia in 26 621 health checkup persons in Guangzhou city and analysis of associated diseases[J].Chin Trop Med,2006,6(6):1082-1084.(in Chinese)古萍.广州市体检人群高尿酸血症患病情况及相关疾病分析[J].中国热带医学,2006,6(6):1082-1084.
|
|
[7]PETTA S,CAMMA C,CABIBI D,et al.Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther,2011,34(7):757-766.
|
|
[8]HWANG IC,SUH SY,SUH AR,et al.The relationship between normal serum uric acid and nonalcoholic fatty liver disease[J].J Korean Med Sci,2011,26(3):386-391.
|
|
[9]ONAT A,UYAREL H,HERGENC G,et al.Serum uric acid is a determinant of metabolic syndrome in a population-based study[J].Am J Hypertens,2006,19(10):1055-1062.
|
|
[10]Chinese Society of Endocrinology,Chinese Medical Association.Chinese expert consensus on the treatment of hyperuricemia and gout[J].Chin J Endocrinol Metab,2013,29(11):913-920.(in Chinese)中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920.
|
|
[11]WANG T,BI Y,XU M,et al.Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese[J].Endocrine,2011,40(1):109-116.
|
|
[12]KANSUI Y,OHTSUBO T,GOTO K,et al.Association of serum uric acid with blood pressure in Japanese men.Cross-sectional study in work-site group[J].Circ J,2011,75(12):2827-2832.
|
|
[13]CHEN JH,CHUANG SY,CHEN HJ,et al.Serum uric acid level as an independent risk factor for all-cause,cardiovascular,and ischemic stroke mortality:a Chinese cohort study[J].Arthritis Rheum,2009,61(2):225-232.
|
|
[14]NAKAGAWA T,KANG DH,FEIG D,et al.Unearthing uric acid:an ancient factor with recently found significance in renal and cardiovascular disease[J].Kidney Int,2006,69(10):1722-1725.
|
|
[15]ZHANG XJ.Pathogenesis and typing diagnosis of hyperuricemia[J].Chin J Cardiovase Med,2010,15(6):418-420.(in Chinese)张新军.高尿酸血症的发病机制与分型诊断[J].中国心血管杂志,2010,15(6):418-420.
|
|
[16]LI Y,XU C,YU C,et al.Association of serum uric acid level with non-alcoholic fatty liver disease:a cross-sectional study[J].J Hepatol,2009,50(5):1029-1034.
|
|
[17]XU CF,YU CH,XU L,et al.High serum uric acid increases the risk for nonalcoholic Fatty liver disease:a prospective observational study[J].PLo S One,2010,5(7):e11578.
|
|
[18]LEE JW,CHO YK,RYAN M,et al.Serum uric acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects:a 5-year retrospective cohort study[J].Gut Liver,2010,4(3):378-383.
|
|
[19]SIROTA JC,MCFANN K,TARGHER G,et al.Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States:liver ultrasound data from the National Health and Nutrition Examination Survey[J].Metabolism,2013,62(3):392-399.
|
|
[20]SERTOGLU E,ERCIN CN,CELEBI G,et al.The relationship of serum uric acid with non-alcoholic fatty liver disease[J].Clin Biochem,2014,47(6):383-388.
|
|
[21]XU C,WAN X,XU L,et al.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia:one stone hits two birds[J].J Hepatol,2015,62(6):1412-1419.
|
|
[22]EVANS JL,MADDUX BA,GOLDFINE ID.The molecular basis for oxidative stress-induced insulin resistance[J].Antioxid Redox Signal,2005,7(7-8):1040-1052.
|
|
[23]PESSIN JE,SALTIEL AR.Signaling pathways in insulin action:molecular targets of insulin resistance[J].J Clin Invest,2000,106(2):165-169.
|
|
[24]ZHU Y,HU Y,HUANG T,et al.High uric acid directly inhibits insulin signalling and induces insulin resistance[J].Biochem Biophys Res Commun,2014,447(4):707-714.
|
|
[25]AMES BN,CATHCART R,SCHWIERS E,et al.Uric acid provides an antioxidant defense in humans against oxidant-and radicalcaused aging and cancer:a hypothesis[J].Proc Natl Acad Sci U S A,1981,78(11):6858-6862.
|
|
[26]BAGNATI M,PERUGINI C,CAU C,et al.When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation:a study using uric acid[J].Biochem J,1999,340(Pt1):143-152.
|
|
[27]SAUTIN YY,NAKAGAWA T,ZHARIKOV S,et al.Adverse effects of the classic antioxidant uric acid in adipocytes:NADPH oxidase-mediated oxidative/nitrosative stress[J].Am J Physiol Cell Physiol,2007,293(2):c584-c596.
|
|
[28]LANASPA MA,SANCHEZ-LOZADA LG,CHOI YJ,et al.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:potential role in fructose-dependent and-independent fatty liver[J].J Biol Chem,2012,287(48):40732-40744.
|
|
[29]CHOI YJ,SHIN HS,CHOI HS,et al.Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J].Lab Invest,2014,94(10):1114-1125.
|
|
[30]LEEMANS JC,CASSEL SL,SUTTERWALA FS.Sensing damage by the NLRP3 inflammasome[J].Immunol Rev,2011,243(1):152-62.
|
|
[31]WANG YG,FANG WL,WEI J,et al.The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice[J].J Chin Med Assoc,2013,76(12):686-692.
|
|
[32]MARTINON F,PETRILLI V,MAYOR A,et al.Gout-associated uric acid crystals activate the NALP3 inflammasome[J].Nature,2006,440(7081):237-441.
|
|
[33]TSCHOPP J,SCHRODER K.NLRP3 inflammasome activation:the convergence of multiple signalling pathways on ROS production?[J].Nat Rev Immunol,2010,10(3):210-215.
|
|
[34]ZHOU R,YAZDI AS,MENU P,et al.A role for mitochondria in NLRP3 inflammasome activation[J].Nature,2011,469(7329):221-225.
|
|
[35]XU X,SO JS,PARK JG,et al.Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP[J].Semin Liver Dis,2013,33(4):301-311.
|
|
[36]LANASPA MA,CICERCHI C,GARCIA G,et al.Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver[J].PLo S One,2012,7(11):e48801.
|
|
[37]CICERCHI C,LI N,KRATZER J,et al.Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation:evolutionary implications of the uricase loss in hominids[J].Faseb J,2014,28(8):3339-3350.
|
|
[38]JUNG EJ,KWON SW,JUNG BH,et al.Role of the AMPK/SREBP-1 pathway in the development of orotic acid-induced fatty liver[J].J Lipid Res,2011,52(9):1617-1625.
|
|
[39]NAKATSU Y,SENO Y,KUSHIYAMA A,et al.The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model[J].Am J Physiol Gastrointest Liver Physiol,2015,309(1):g42-g51.
|
DownLoad: